London: Poor diet is a major cause behind the COVID-19 deaths and the Indians must urgently cut down on ultra-processed food to build resilience against the deadly virus, a leading Indian-origin cardiologist in the UK has cautioned.
Dr Aseem Malhotra, who is among the UK's National Health Service (NHS) frontline medics and also a professor of evidence based medicine, said that obesity and excess weight were the "elephant in the room" that need to be addressed as a major factor behind the deaths from the coronavirus.
"India is particularly vulnerable, having a very high prevalence of lifestyle related diseases," says the 42-year-old medic, who is on a mission to spread awareness around lifestyle changes as a major weapon in the fight against coronavirus.
"Specifically, conditions such as Type 2 diabetes, high blood pressure, heart disease are three of the major risk factors for death from COVID-19. This is rooted in excess body fat, a cluster of conditions known as a metabolic syndrome," he noted.
Western countries such as the US and the UK have seen some of the highest death rates from COVID-19 in the world, which are likely to correlate with unhealthy lifestyles.
"The elephant in the room is that the baseline general health in many Western populations was already in a horrendous state to begin with. In the UK and US, more than 60 per cent of adults are overweight or obese," he pointed out.
In the US, less than one in eight people are metabolically healthy, which means having normal blood pressure, having a weight circumference if you are a man less than a 102cm and less than 88cm for a woman and healthy levels of blood sugar and good cholesterol.
"There's no such thing as a healthy weight, only a healthy person. If people try to maintain all these metabolic health parameters through a healthy lifestyle, this could potentially be achieved within a few weeks of just a change of diet," says Malhotra, who is from New Delhi.
A recent report in the 'Nature' science journal revealed that patients with Type 2 diabetes and metabolic syndrome might have up to 10 times greater risk of death when they contract COVID-19 and called for mandatory glucose and metabolic control of Type 2 diabetes patients to improve outcomes.
Malhotra warns that the medications that are used for Type 2 diabetes and many of the other conditions have "very, very marginal effects" in terms of improving lifespan or reducing risk of death, which most people are not made aware of, and they also come with side effects.
"This is not to say that medications should be discontinued but the lifestyle changes are considerably more impactful on health and will reduce the need for medication. The positive news is that you can reverse this, but it is not being made aware to patients or practised by the majority of physicians as lifestyle prescriptions in India," he said.
Based on his own clinical experience and also reflected across medical literature, the expert recommends giving up ultra-processed foods, which covers any packaged food that comes with five or more ingredients, because usually these are high in sugar, starch, unhealthy oils, additives and preservatives.
In the UK, these foods now represent more than 50 per cent of the diet, which he says is "really quite staggering and shocking".
Similar figures are there for the US and probably to some degree reflect why there is specifically more increased death rates from COVID-19 in these countries.
"So, what I would advise the Indian population is to completely cut out these types of food from their diet, make sure that you are cooking from scratch, do not snack," the doctor said.
"Beyond that, the other issue in Indian diet is that we have a very high intake of refined carbohydrate foods, these are also foods that are particularly harmful in excess because they raise glucose and insulin and therefore rooted in many of these chronic conditions such as Type 2 diabetes, high blood pressure and heart disease this involves too much consumption of flour and white rice.
"These must be swapped with a variety of wholefoods such as vegetables and fruits and for those who are non-vegetarians, it is completely fine to eat red meat as well as full fat dairy products, eggs, fish etc," he said.
In reference to recent data on the higher risk faced by black, Asian and minority ethnic (BAME) communities in the UK from coronavirus, the NHS doctor believes that disparity is also cultural or lifestyle related.
"South Asians have been found vulnerable because the prevalence of metabolic syndrome is three-four-fold higher in the population. Indians, therefore, I think have to be extra careful with their diet and what they are consuming and they should also not have the illusion of protection just because they are given a normal body mass index (BMI). Extra body fat, particularly around the waist, is much more detrimental to health than using outdated indices such as BMI to define health risk," he said.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Berlin: Scientists have identified highly effective antibodies against the novel coronavirus, which they say can lead to the development of a passive vaccination for COVID-19.
Unlike in active vaccination, passive vaccination involves the administration of ready-made antibodies, which are degraded after some time.
However, the effect of a passive vaccination is almost immediate, whereas with an active vaccination it has to build up first, the researchers said.
The research, published in the journal Cell, also shows that some SARS-CoV-2 antibodies bind to tissue samples from various organs, which could potentially trigger undesired side effects.
The scientists at the German Center for Neurodegenerative Diseases (DZNE) and Charite - Universitatsmedizin Berlin isolated almost 600 different antibodies from the blood of individuals who had overcome COVID-19, the disease triggered by SARS-CoV-2.
By means of laboratory tests, they were able to narrow this number down to a few antibodies that were particularly effective at binding to the virus.
The researchers then produced these antibodies artificially using cell cultures.
The so-called neutralising antibodies bind to the virus, as crystallographic analysis reveals, and thus prevent the pathogen from entering cells and reproducing, they said.
In addition, virus recognition by antibodies helps immune cells to eliminate the pathogen. Studies in hamsters -- which, like humans, are susceptible to infection by SARS-CoV-2 -- confirmed the high efficacy of the selected antibodies.
If the antibodies were given after an infection, the hamsters developed mild disease symptoms at most. If the antibodies were applied preventively -- before infection -- the animals did not get sick, said Jakob Kreye, coordinator of the research project.
The researchers noted that treating infectious diseases with antibodies has a long history.
For COVID-19, this approach is also being investigated through the administration of plasma derived from the blood of recovered patients. With the plasma, antibodies of donors are transferred, they said.
"Ideally, the most effective antibody is produced in a controlled manner on an industrial scale and in constant quality. This is the goal we are pursuing," said Momsen Reincke, first author of the research.
Three of our antibodies are particularly promising for clinical development, explained Harald Pruss, a research group leader at the DZNE and also a senior physician at Charite Universitatsmedizin Berlin.
"Using these antibodies, we have started to develop a passive vaccination against SARS-CoV-2," Pruss said.
In addition to the treatment of patients, preventive protection of healthy individuals who have had contact with infected persons is also a potential application, the researchers said.
How long the protection lasts will have to be investigated in clinical studies, they said.
This is because, unlike in active vaccination, passive vaccination involves the administration of ready-made antibodies, which are degraded after some time, Pruss said. In general, the protection provided by a passive vaccination is less persistent than that provided by an active vaccination, the researchers said.
However, the effect of a passive vaccination is almost immediate, whereas with an active vaccination it has to build up first, they said.
It would be best if both options were available so that a flexible response could be made depending on the situation, Pruss added.